Hub Services Contract With DMTC Extended
17 August 2020 A $3.9 million contract extension will help put cutting-edge capabilities into the hands of Australia’s service men and women, and build industrial supply chain capacity. Minister for Defence Industry Melissa Price said the contract extension…
MTPConnect’s REDI Initiative Partners With APR.Intern
18 August 2020 A new funding partnership between APR.Intern and MTPConnect will increase workforce capabilities and strengthen research translation within Australia’s medtech, biotech and pharmaceutical sector. Under the agreement, MTPConnect’s REDI initiative will provide 20 businesses in the medtech,…
Starpharma signs new DEP® partnership with Chase Sun
17 August 2020 Starpharma today announced that it has signed a new research partnership with leading Chinese Pharmaceutical company Tianjin Chase Sun Pharmaceutical Co., Ltd[1]. (stock code 300026; Chase Sun), to develop several DEP® nanoparticle formulations for an anti-infective…
Australia leads on elimination of global cervical cancer
14 August 2020 Release Date: 12 August 2020 Australia has led the way by sponsoring a resolution at the most recent World Health Assembly calling for World Health Organization (WHO) Member States to adopt the WHO Global Strategy:…
$2 million project to transform University of Melbourne’s Dookie Agricultural College
13 August 2020 Upgrades will be made to the University of Melbourne’s Dookie campus thanks to a $2 million funding boost announced today by the Minister for Training and Skills and Higher Education Gayle Tierney. The funding will…
Bionics Institute welcomes Dr Sherryl Wagstaff to Board
13 August 2020 Dr Sherryl Wagstaff (MBBS, FRACS MBA (MBS) GAICD), an ear-nose-and-throat (ENT) specialist and Medical Director at Epworth Eastern Hospital recently joined the Board of the Bionics Institute. Dr Wagstaff has been working with the Bionics…
CSIRO sets sights on new ‘Team Australia’ missions program
13 August 2020 CSIRO, Australia’s national science agency, will work with the government, universities, industry and the community, on a new missions program to bolster Australia’s COVID-19 recovery and build long term resilience. The program of large scale,…
Independent publication strengthens case for Noxopharm’s Veyonda® as a safe and possibly life-prolonging treatment in late- stage prostate cancer
11 August 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) is pleased to announce the publication of the first manuscript of the LuPIN trial in the journal, European Urology Oncology. This journal is the first official publication…
Sienna Cancer Diagnostics Ltd (Sienna) becomes a wholly owned subsidiary of BARD1 Life Sciences Ltd
10 August 2020 Release date: 4 August 2020 Dear Valued Stakeholders, We are pleased to inform you that on 28 July 2020, Sienna Cancer Diagnostics Ltd (Sienna) became a wholly owned subsidiary of BARD1 Life Sciences Ltd (BARD1…
Atmo Biosciences wins $620K grant to advance commercialization of ingestible gas-sensing capsule to diagnose gut disorders
6 August 2020 Release date: 20 July 2020 Atmo Biosciences has been awarded a $620,000 Australian Government grant through the BioMedTech Horizons (BMTH) program. Delivered by MTPConnect and funded by the Medical Research Future Fund, the BMTH program supports the…
New head lice treatment approved for use in USA
6 August 2020 Release date: 3 August 2020 A new prescription head lice treatment, developed by University of Melbourne Associate Professor Vern Bowles, has been given Food and Drug Administration (FDA) approval, allowing it to be sold in…
Funding Injection To Advance DMTC Vaccine Development
6 August 2020 A novel Q Fever vaccine is progressing to pre-clinical trials following a $1.87 million investment from the Department of Health into DMTC’s national Medical Countermeasures (MCM) Initiative. DMTC will work with research and industry partners to manage…
